IGF2 and colorectal cancer: Both IGF2 and IRS4 were initially discovered by CESAM as enhancer hijacking target genes using CNV breakpoints profiled by microarray with much larger sample sizes (378 colorectal cancers and 497 lung squamous cell carcinomas) (13).